AKASAKAg-lab ClinicLooking ahead to your health.Request a consultation
EXOSOME THERAPY

Exosome therapy.
Whole-body care, with treatment focused where you need it.

No need to have your fat collected.
Whole-body IV treatment, with local treatment chosen for your needs.

Particle count per 2mL vial2.62 trillion particlesView analysis data

  • No fat collection
  • Whole-body + local care
  • Testing and follow-up

See how collection, cell culture, treatment contents and quality checks differ

We bring together whole-body IV treatment, local treatment and testing to track changes over time. Your doctor works with you to plan care around your health and goals.

Whole-body
wellbeing

Skin and
aesthetic care

Joint health and mobility
wellbeing

Regenerative medicine
options

INSIDE AND BEYOND.

A healthier future, from within.

IV treatment for the whole body

After discussing your overall health and treatment goals,
exosomes are given by intravenous infusion.
The treatment plan considers more than one area,
taking your overall health into account.

Exosomes
circulate throughout the body

Supporting whole-body
wellbeing

Through ongoing testing,
monitor changes

Whole-body IV + local treatment + testing. A 12-session plan.

The 12-session plan combines whole-body IV treatment, a choice of local treatment and testing to monitor your progress.
At each visit, you and your doctor choose the local treatment area based on your needs and condition.

Included at each visit

Whole-body IV treatment(intravenous infusion)

  • Supporting whole-body
  • Immunity, metabolism and aging-related health
  • Maintaining health from within
+
Choose at each visit

Local treatment

  • Facial and skin aesthetic treatment
  • Joint and muscle treatment
  • Tailored to your needs

Choose the area you want to focus on

Discuss with your doctor which area is most suitable for your condition and goals at that visit.

For aesthetic goals

Skin firmness and radianceFine linesSkin quality
Entire face
Eye area
Neck and jawline

For pain, movement and function

Pain reliefRestoring functionSports performance
Knees
Shoulders
Lower back
Muscles and other areas

Other areas may also be considered following a doctor's examination.

How your treatments can be combined

The combination can be adjusted to your condition at every visit.

For someone focused on skin and aesthetics

Example 1: skin and aesthetic care

Ongoing care for skin firmness and radiance alongside overall health maintenance.

Whole-body IV treatment + Face, eyes and neck, for example
For someone who plays sports

Example 2: sports and recovery

Supporting recovery in areas of concern while considering overall physical condition.

Whole-body IV treatment + Knees, shoulders and muscles, for example
For someone living with chronic pain

Example 3: managing pain

Addressing painful areas alongside overall health maintenance.

Whole-body IV treatment + Lower back, knees and shoulders, for example

Twelve sessions. A clearer picture of your health over time.

Treatment and testing at each visit help monitor changes and inform the next treatment.

1First visit

Baseline testing

Systemic + local administration
(select an area)

2–3Early stage

Review changes

Systemic + local administration
(select an area)

4–6Middle stage

Evaluate and adjust

Systemic + local administration
(select an area)

7–9Later stage

Optimize the treatment plan

Systemic + local administration
(select an area)

10–12Completion

Overall assessment

Plan future care

Testing over time helps you and your doctor see what is changing.

Regenerative treatments can differ,
even when they share the same broad goal.

At AKASAKA g-lab Clinic, treatment is planned while continually reviewing your condition.
We select exosome therapy to reduce the harvesting, culture and waiting steps.

Autologous adipose-derived stem cell therapy

ADIPOSE STEM CELL THERAPY

Stem cells are collected from your own fat,
then cultured before administration.

g-lab exosome therapy

EXOSOME THERAPY

An analyzed exosome preparation is used,
with administration planned for your condition.

Your own fat must be collected

A procedure is required to collect fat.

Treatment process

No need to collect your fat

There is no physical burden from fat collection.

Cells are cultured

The collected cells are grown in culture to increase their number.

Physical burden

No waiting for cells to be cultured

We use a preparation that has already been manufactured and analyzed.

Time is needed before administration

From collection to administration, several weeks to several months may be needed.

Time to treatment

Plan treatment around your visit to Japan

There is no waiting for harvesting or culture.

Cell quality varies from person to person

Stem cell characteristics vary with age, health and lifestyle.

Quality consistency

A quality-controlled preparation

We use preparations manufactured and analyzed against defined standards.

Living cells themselves are administered

The administered cells are harvested and cultured from your own body.

What is administered

Exosomes released by cells are administered

Living cells themselves are not administered.

Ongoing treatment requires planning

Storage, culture and administration schedules are planned in advance.

Continuing treatment

Treatment can continue according to your condition

It can be incorporated into a 12-session program, with treatment considered at appropriate times.

Detailed analysis is not routinely carried out

Analysis and verification methods differ by treatment and facility.

Analysis of the treatment preparation

Detailed analysis of the preparation itself

miRNA and IPA analyses are used to examine preparation characteristics.

Care continues over time,
with treatment adjusted as your condition changes.

This is the approach to exosome therapy at AKASAKA g-lab Clinic.

What matters to us

Evidence-informed choices

We seek better options based on findings from research.

Care tailored to you

Discuss with your doctor and choose a plan suited to your goals and condition.

Looking toward future health

We consider both your health today and your needs in the years ahead.

A closer look at changes
you may not notice.

Blood miRNA analysis examines your current condition and changes in the internal environment associated with cancer.
We follow changes over time, comparing with your previous results rather than relying on one result.

TheoriaScreen Wellness Model W

Wellness model

Cellular health and aging-related indicators

We review current physical condition through indicators of cellular health.

Cellular health and resilience

Are your cells and tissues maintaining healthy, stable function?

Cellular stress

Are low oxygen levels or oxidative stress putting strain on cells?

Chronic inflammation in the body

Is inflammation continuing even without noticeable symptoms?

Tissue stiffening and aging

Are there changes linked to stiffening or fibrosis in the skin, blood vessels, organs or bones?

TheoriaScreen Protect Model P

Protect model

The internal environment associated with cancer

We examine changes associated with an environment in which cancer may grow.
(This is not a test to diagnose cancer.)

Control of excessive cell growth

Is the ability to prevent excessive cell growth maintained?

The environment around cancer cells

Are there changes in blood vessels, oxygen supply or surrounding tissues associated with cancer growth?

Cell growth and activity signals

Are signals associated with cell proliferation and activity becoming stronger?

Stiffening and fibrosis in surrounding tissues

Are there signs of increasing tissue stiffness or fibrosis?

Your results matter most in the context of your previous tests.

1

First test

Understand your current condition

Establish a baseline of your current health.

2

Second test

Compare with your previous test

Compare with previous results to identify small changes.

3

Third test and beyond

Review the direction of change

Accumulated data help assess treatment and lifestyle effects as a whole.

Finding small changes
can help you plan for future health.

Illness or discomfort may be preceded by gradual changes within the body. Understanding those changes now can help you consider future care.

Behind this testing,
world-leading exosome research.

Professor Takahiro Ochiya has long led research into exosomes and miRNA.
g-lab uses Theoria testing developed from that research for ongoing health management.

Professor Takahiro Ochiya

Takahiro OchiyaProfessor

A long-standing leader in exosome and miRNA research
Theoria Science Founder / CSO
Specially Appointed Professor at Tokyo Medical University

Exosome research
World ranking

No.1Seven consecutive years

Recognized by researchers around the world

Expertscape

Exosome research

World No.1

Ranked among the world's leaders through expert analysis

ScholarGPS™

Exosome research

World No.1

Ranked among the world's leaders for long-term research achievements

Clarivate

Highly Cited Researchers

2024

Recognized as a Highly Cited Researcher

Source: Tokyo Medical University news (14 November 2025)

Turning laboratory findings into tools to track your health.

1

Professor Ochiya's research

Findings from many years of exosome and miRNA research.

2

Theoria miRNA testing

Research-based testing to help assess your current health.

3

Ongoing monitoring at g-lab

Regular testing helps follow changes and informs health management.

We examine more than
the patient's body.

g-lab also analyzes the exosome preparation itself before administration.

miRNA Analysis

miRNA analysis

(Analysis of the genetic information in the preparation)

IPA Analysis

IPA analysis

(Analysis of functions and pathways)

Looking at both your health and the preparation through a scientific lens.
So you can make a more informed choice.

Numbers matter.
But numbers alone are not enough.

How much is present matters.
So do the contents and their balance.

Particle count

2.62 trillion

Per vial
2.62 × 1012 particles

miRNA composition and relative proportions

Tumor Suppressor
miRNA

88%

Associated with tumor suppression
miRNA 88%

88%Tumor Suppressor
miRNA
(tumor-suppressor classification)

OncomiR (oncogenic classification) 12%

Look at both how much is present and what it contains.

01

Examine quantity

Are sufficient particles present?

02

Examine contents

Which miRNAs are present?

03

Examine balance

Review miRNA composition across the preparation

04

Explore related functions

Use IPA to explore associations with biological pathways

IPA: exploring what the miRNAs may be associated with

Detected miRNAs are compared with literature and databases,
to explore the bodily functions they have been linked to in published research.

Inflammation

Immunity

Blood vessels

Nerves

miRNA
PROFILE

Cell repair

Reproductive function

Hormones

Cancer-related pathways

IPA explores associated biological functions; it does not guarantee treatment effectiveness or safety.

Analysis data

View the analysis materials underlying the information on this page.

What is commonly shown

  • Focus on particle count
  • Contents may be difficult to see
  • IPA information may be absent

What g-lab examines

  • Particle count
  • miRNA composition
  • Tumor-suppressor miRNA: 88% of the classified subset
  • IPA analysis

Understand your health.
Understand the preparation.

Your health and the treatment you receive both matter.
Our doctors consider both when planning your care.

PATIENT

Model W / Model P
Review current physical condition

PRODUCT

Particle count / miRNA / IPA
Examine the administered preparation

DOCTOR

The doctor considers both sets of information
to plan treatment

Plan your consultation in Japan before you travel

Understand the proposed care, suitability and practical arrangements before booking your trip. A visit to Japan gives you the opportunity to discuss testing and a continuing care plan directly with the clinic.

Before your visit

Request a consultation about your goals, medical background and preferred travel dates. Interpreter availability and scope must be confirmed in advance.

Travel and the 12-session plan

Discuss visit intervals and the length of stay with the clinic. A short stay may not accommodate a full program; a return-visit plan may be needed.

Fees and travel costs

Request an individual estimate for consultation, testing and treatment. Flights and hotels are separate. Confirm interpreter fees and cancellation terms before making arrangements.

Questions before you decide

Is my request a confirmed appointment?

No. The clinic will contact you to discuss availability and confirm the appointment.

Can I receive a complete 12-session program in one trip?

Whether the full program can be completed in one trip depends on your medical assessment and the agreed time between sessions. Please discuss your travel plans with the clinic before booking.

Are travel and interpreter arrangements included?

Flights and hotels are separate. Ask the clinic to confirm interpreter support, arrangements and any additional fees before you travel.

Confirm the full cost before starting

This is self-pay care. Ask for the proposed treatment details and an itemized estimate. Discuss risks, side effects, approval status and the evidence for the specific preparation before deciding.

Request a consultation →
YOUR HEALTH, YOUR FUTURE.

Your health. Your goals.
Your treatment plan.

Discuss a treatment plan with your doctor after reviewing your condition and goals.

Request a consultation→

This treatment is privately funded. During your consultation, discuss suitability, costs, risks and side effects, and the approval status of the preparation. Results vary from person to person; this page does not guarantee treatment outcomes.

Particle count is calculated per 2mL vial from a measured concentration of 1.31×10¹² particles/mL. The miRNA percentages are normalized by expression level within the classified subset of the top-100 miRNAs. This subset accounts for about 53% of the total and includes miRNAs whose tumor-suppressing or tumor-promoting roles have been reported in the literature. miRNAs with conflicting reports or without an established classification are excluded. These results apply only to the analyzed lot, not to every preparation or lot.

Reviewed by Dr. Tomokazu Gima, Director, AKASAKA g-lab CLINIC (Neurosurgery / Regenerative Medicine). 5 October 2026.

Treatment and fee information →
ご予約カウンセリング無料AIに相談無料・匿名